SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-22-028523
Filing Date
2022-10-17
Accepted
2022-10-17 09:00:07
Documents
3
Period of Report
2022-10-17

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 409985
2 def14a_001.jpg GRAPHIC 2678
3 def14a_002.jpg GRAPHIC 1790
  Complete submission text file 0001493152-22-028523.txt   417396
Mailing Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734
Business Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

IRS No.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-40388 | Film No.: 221312665
SIC: 2834 Pharmaceutical Preparations